Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Editorial

New Drug Treatment Paradigms for Metabolic and Neurological Disorders

Author(s): Senthilkumar Sivanesan

Volume 25, Issue 33, 2019

Page: [3499 - 3499] Pages: 1

DOI: 10.2174/138161282533191119145548

Next »
[1]
Upadhya D, Shetty AK. Extracellular vesicles as therapeutics for brain injury and disease. Curr Phar Des 2019; 25(33): 3500-5.
[2]
Kabir MT, Sufian MA, Uddin MS, et al. NMDA receptor antagonists: repositioning of memantine as a multitargeting agent for Alzheimer’s therapy. Curr Phar Des 2019; 25(33): 3506-18.
[3]
Kabir MT, Uddin MS, Begum MM, et al. Cholinesterase inhibitors for Alzheimer’s disease: multitargeting strategy based on anti-Alzheimer’s drugs repositioning. Curr Phar Des 2019; 25(33): 3519-35.
[4]
Öztürk Y, Öztürk N. Plant- and nutraceutical-based approach for the management of diabetes and its neurological complications: a narrative review. Curr Phar Des 2019; 25(33): 3536-49.

© 2024 Bentham Science Publishers | Privacy Policy